 | • レポートコード：B-GIR09F2695 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アリスキレンの世界市場について調べ、まとめました。種類別セグメントは、150mg錠、300mg錠等、用途別セグメントは、病院、ドラッグストア等に区分しました。アリスキレンの世界市場概観、企業動向、企業別アリスキレンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アリスキレンの市場概観 ・アリスキレンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アリスキレンの企業別販売動向、市場シェア、市場集中度、競争動向 ・アリスキレンの世界市場規模 ・アリスキレンの北米市場分析（アメリカ、カナダ、メキシコ等） ・アリスキレンのアメリカ市場規模推移 ・アリスキレンのカナダ市場規模推移 ・アリスキレンのメキシコ市場規模推移 ・アリスキレンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アリスキレンのドイツ市場規模推移 ・アリスキレンのイギリス市場規模推移 ・アリスキレンのロシア市場規模推移 ・アリスキレンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アリスキレンの日本市場規模推移 ・アリスキレンの中国市場規模推移 ・アリスキレンの韓国市場規模推移 ・アリスキレンのインド市場規模推移 ・アリスキレンの東南アジア市場規模推移 ・アリスキレンの南米市場分析（ブラジル、アルゼンチン等） ・アリスキレンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アリスキレンの種類別分析/販売量、売上、市場シェア（150mg錠、300mg錠） ・アリスキレンの用途別分析/市場規模（病院、ドラッグストア） ・アリスキレンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アリスキレンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.
Scope of the Report:
The global Aliskiren market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Aliskiren.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Aliskiren market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Aliskiren market by product type and applications/end industries.
Market Segment by Companies, this report covers
Noden Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
150 mg Tablet
300 mg Tablet
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Aliskiren Market Overview
1.1 Product Overview and Scope of Aliskiren
1.2 Classification of Aliskiren by Types
1.2.1 Global Aliskiren Revenue Comparison by Types (2019-2024)
1.2.2 Global Aliskiren Revenue Market Share by Types in 2018
1.2.3 150 mg Tablet
1.2.4 300 mg Tablet
1.3 Global Aliskiren Market by Application
1.3.1 Global Aliskiren Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Aliskiren Market by Regions
1.4.1 Global Aliskiren Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Aliskiren Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Aliskiren Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Aliskiren Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Aliskiren Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Aliskiren Status and Prospect (2014-2024)
1.5 Global Market Size of Aliskiren (2014-2024)
2 Manufacturers Profiles
2.1 Noden Pharma
2.1.1 Business Overview
2.1.2 Aliskiren Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Noden Pharma Aliskiren Revenue, Gross Margin and Market Share (2017-2018)
3 Global Aliskiren Market Competition, by Players
3.1 Global Aliskiren Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Aliskiren Players Market Share
3.2.2 Top 10 Aliskiren Players Market Share
3.3 Market Competition Trend
4 Global Aliskiren Market Size by Regions
4.1 Global Aliskiren Revenue and Market Share by Regions
4.2 North America Aliskiren Revenue and Growth Rate (2014-2019)
4.3 Europe Aliskiren Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Aliskiren Revenue and Growth Rate (2014-2019)
4.5 South America Aliskiren Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Aliskiren Revenue and Growth Rate (2014-2019)
5 North America Aliskiren Revenue by Countries
5.1 North America Aliskiren Revenue by Countries (2014-2019)
5.2 USA Aliskiren Revenue and Growth Rate (2014-2019)
5.3 Canada Aliskiren Revenue and Growth Rate (2014-2019)
5.4 Mexico Aliskiren Revenue and Growth Rate (2014-2019)
6 Europe Aliskiren Revenue by Countries
6.1 Europe Aliskiren Revenue by Countries (2014-2019)
6.2 Germany Aliskiren Revenue and Growth Rate (2014-2019)
6.3 UK Aliskiren Revenue and Growth Rate (2014-2019)
6.4 France Aliskiren Revenue and Growth Rate (2014-2019)
6.5 Russia Aliskiren Revenue and Growth Rate (2014-2019)
6.6 Italy Aliskiren Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Aliskiren Revenue by Countries
7.1 Asia-Pacific Aliskiren Revenue by Countries (2014-2019)
7.2 China Aliskiren Revenue and Growth Rate (2014-2019)
7.3 Japan Aliskiren Revenue and Growth Rate (2014-2019)
7.4 Korea Aliskiren Revenue and Growth Rate (2014-2019)
7.5 India Aliskiren Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Aliskiren Revenue and Growth Rate (2014-2019)
8 South America Aliskiren Revenue by Countries
8.1 South America Aliskiren Revenue by Countries (2014-2019)
8.2 Brazil Aliskiren Revenue and Growth Rate (2014-2019)
8.3 Argentina Aliskiren Revenue and Growth Rate (2014-2019)
8.4 Colombia Aliskiren Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Aliskiren by Countries
9.1 Middle East and Africa Aliskiren Revenue by Countries (2014-2019)
9.2 Saudi Arabia Aliskiren Revenue and Growth Rate (2014-2019)
9.3 UAE Aliskiren Revenue and Growth Rate (2014-2019)
9.4 Egypt Aliskiren Revenue and Growth Rate (2014-2019)
9.5 Nigeria Aliskiren Revenue and Growth Rate (2014-2019)
9.6 South Africa Aliskiren Revenue and Growth Rate (2014-2019)
10 Global Aliskiren Market Segment by Type
10.1 Global Aliskiren Revenue and Market Share by Type (2014-2019)
10.2 Global Aliskiren Market Forecast by Type (2019-2024)
10.3 150 mg Tablet Revenue Growth Rate (2014-2024)
10.4 300 mg Tablet Revenue Growth Rate (2014-2024)
11 Global Aliskiren Market Segment by Application
11.1 Global Aliskiren Revenue Market Share by Application (2014-2019)
11.2 Aliskiren Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Aliskiren Market Size Forecast (2019-2024)
12.1 Global Aliskiren Market Size Forecast (2019-2024)
12.2 Global Aliskiren Market Forecast by Regions (2019-2024)
12.3 North America Aliskiren Revenue Market Forecast (2019-2024)
12.4 Europe Aliskiren Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Aliskiren Revenue Market Forecast (2019-2024)
12.6 South America Aliskiren Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Aliskiren Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Aliskiren Picture
Table Product Specifications of Aliskiren
Table Global Aliskiren and Revenue (Million USD) Market Split by Product Type
Figure Global Aliskiren Revenue Market Share by Types in 2018
Figure 150 mg Tablet Picture
Figure 300 mg Tablet Picture
Table Global Aliskiren Revenue (Million USD) by Application (2014-2024)
Figure Aliskiren Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Aliskiren Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Aliskiren Revenue (Million USD) and Growth Rate (2014-2024)
Table Noden Pharma Basic Information, Manufacturing Base and Competitors
Table Noden Pharma Aliskiren Type and Applications
Table Noden Pharma Aliskiren Revenue, Gross Margin and Market Share (2017-2018)
Table Global Aliskiren Revenue (Million USD) by Players (2014-2019)
Table Global Aliskiren Revenue Share by Players (2014-2019)
Figure Global Aliskiren Revenue Share by Players in 2017
Figure Global Aliskiren Revenue Share by Players in 2018
Figure Global Top 5 Players Aliskiren Revenue Market Share in 2018
Figure Global Top 10 Players Aliskiren Revenue Market Share in 2018
Figure Global Aliskiren Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Aliskiren Revenue (Million USD) by Regions (2014-2019)
Table Global Aliskiren Revenue Market Share by Regions (2014-2019)
Figure Global Aliskiren Revenue Market Share by Regions (2014-2019)
Figure Global Aliskiren Revenue Market Share by Regions in 2018
Figure North America Aliskiren Revenue and Growth Rate (2014-2019)
Figure Europe Aliskiren Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Aliskiren Revenue and Growth Rate (2014-2019)
Figure South America Aliskiren Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Aliskiren Revenue and Growth Rate (2014-2019)
Table North America Aliskiren Revenue by Countries (2014-2019)
Table North America Aliskiren Revenue Market Share by Countries (2014-2019)
Figure North America Aliskiren Revenue Market Share by Countries (2014-2019)
Figure North America Aliskiren Revenue Market Share by Countries in 2018
Figure USA Aliskiren Revenue and Growth Rate (2014-2019)
Figure Canada Aliskiren Revenue and Growth Rate (2014-2019)
Figure Mexico Aliskiren Revenue and Growth Rate (2014-2019)
Table Europe Aliskiren Revenue (Million USD) by Countries (2014-2019)
Figure Europe Aliskiren Revenue Market Share by Countries (2014-2019)
Figure Europe Aliskiren Revenue Market Share by Countries in 2018
Figure Germany Aliskiren Revenue and Growth Rate (2014-2019)
Figure UK Aliskiren Revenue and Growth Rate (2014-2019)
Figure France Aliskiren Revenue and Growth Rate (2014-2019)
Figure Russia Aliskiren Revenue and Growth Rate (2014-2019)
Figure Italy Aliskiren Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Aliskiren Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Aliskiren Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Aliskiren Revenue Market Share by Countries in 2018
Figure China Aliskiren Revenue and Growth Rate (2014-2019)
Figure Japan Aliskiren Revenue and Growth Rate (2014-2019)
Figure Korea Aliskiren Revenue and Growth Rate (2014-2019)
Figure India Aliskiren Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Aliskiren Revenue and Growth Rate (2014-2019)
Table South America Aliskiren Revenue by Countries (2014-2019)
Table South America Aliskiren Revenue Market Share by Countries (2014-2019)
Figure South America Aliskiren Revenue Market Share by Countries (2014-2019)
Figure South America Aliskiren Revenue Market Share by Countries in 2018
Figure Brazil Aliskiren Revenue and Growth Rate (2014-2019)
Figure Argentina Aliskiren Revenue and Growth Rate (2014-2019)
Figure Colombia Aliskiren Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Aliskiren Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Aliskiren Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Aliskiren Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Aliskiren Revenue Market Share by Countries in 2018
Figure Saudi Arabia Aliskiren Revenue and Growth Rate (2014-2019)
Figure UAE Aliskiren Revenue and Growth Rate (2014-2019)
Figure Egypt Aliskiren Revenue and Growth Rate (2014-2019)
Figure Nigeria Aliskiren Revenue and Growth Rate (2014-2019)
Figure South Africa Aliskiren Revenue and Growth Rate (2014-2019)
Table Global Aliskiren Revenue (Million USD) by Type (2014-2019)
Table Global Aliskiren Revenue Share by Type (2014-2019)
Figure Global Aliskiren Revenue Share by Type (2014-2019)
Figure Global Aliskiren Revenue Share by Type in 2019
Table Global Aliskiren Revenue Forecast by Type (2019-2024)
Figure Global Aliskiren Market Share Forecast by Type (2019-2024)
Figure Global 150 mg Tablet Revenue Growth Rate (2014-2019)
Figure Global 300 mg Tablet Revenue Growth Rate (2014-2019)
Table Global Aliskiren Revenue by Application (2014-2019)
Table Global Aliskiren Revenue Share by Application (2014-2019)
Figure Global Aliskiren Revenue Share by Application (2014-2019)
Figure Global Aliskiren Revenue Share by Application in 2019
Table Global Aliskiren Revenue Forecast by Application (2019-2024)
Figure Global Aliskiren Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Aliskiren Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Aliskiren Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Aliskiren Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Aliskiren Revenue Market Forecast (2019-2024)
Figure Europe Aliskiren Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Aliskiren Revenue Market Forecast (2019-2024)
Figure South America Aliskiren Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Aliskiren Revenue Market Forecast (2019-2024)
世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…- 世界のシクロベンザプリン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
- 世界のフェソテロジン市場予測（～2024年） Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB). Scope of the Report: The global Fesoterodine market is valued at xx million USD in 2018 and is expected to reach xx million USD by…
- 世界のダルナビル市場予測（～2024年）：企業別、地域別、種類・用途別 Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. Scope of the Report: The global Darunavir market is valued at xx million USD in 2018 and is expected t…
- 世界のコレセベラム市場予測（～2024年） Colesevelam is a bile acid sequestrant administered orally. Colesevelam is used along with diet, weight loss, and exercise to reduce the amount of cholesterol and certain fatty substances in the blood. Scope of the Report: The global Colesevelam market is valued at xx million USD in 2018 and is expe…